W. Cameron Black

3.7k citations

42 papers · 1.9k indexed · h-index 26

Co-authors: David A. Evans M. David Percival Frédéric Massé Sylvie Desmarais Serge Léger Jean‐Pierre Falgueyret Denis Riendeau Christopher I. Bayly
Topics: Bone Metabolism and Diseases (14 papers)Protease and Inhibitor Mechanisms (13 papers)Inflammatory mediators and NSAID effects (9 papers)
Cited by: Organic Chemistry Pharmaceutical Science Pharmacology
Journals: Journal of the American Chemical Society Analytical Biochemistry Journal of Medicinal Chemistry
Partner nations: Canada United States France

In The Last Decade

W. Cameron Black

42 papers receiving 1.8k citations

Peers

Countries citing papers authored by W. Cameron Black

Since Specialization

Citations

This map shows the geographic impact of W. Cameron Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Cameron Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Cameron Black more than expected).

Fields of papers citing papers by W. Cameron Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Cameron Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Cameron Black. The network helps show where W. Cameron Black may publish in the future.

Co-authorship network of co-authors of W. Cameron Black

This figure shows the co-authorship network connecting the top 25 collaborators of W. Cameron Black. A scholar is included among the top collaborators of W. Cameron Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Cameron Black. W. Cameron Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Testing inter-observer error under a collaborative research framework for studying lithic shape variability 2022 ·Archaeological and Anthropological Sciences ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),W. Cameron Black,(unknown),Emmanuel Ndiema,(unknown),(unknown),(unknown),M. La Grove	15
2	Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy 2011 ·Bioorganic & Medicinal Chemistry Letters ·David Powell,W. Cameron Black,Kelly Bleasby,Chi‐Chung Chan,Denis Deschênes,Marc Gagnon,(unknown),Jocelyne Guay,Sébastien Guiral,Michael J. Hafey,Zheng Huang,Élise Isabel,Yves Leblanc,Angela Styhler,Lijing Xu,Lei Zhang,Renata M. Oballa	15
3	Pharmacokinetics and Metabolism in Rats, Dogs, and Monkeys of the Cathepsin K Inhibitor Odanacatib: Demethylation of a Methylsulfonyl Moiety as a Major Metabolic Pathway 2011 ·Drug Metabolism and Disposition ·Kelem Kassahun,W. Cameron Black,Deborah A. Nicoll‐Griffith,Ian McIntosh,Nathalie Chauret,Stephen H. Day,Elizabeth Rosenberg,(unknown)	25
4	Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Élise Isabel,David Powell,W. Cameron Black,Chi‐Chung Chan,Sheldon N. Crane,Robert J. Gordon,Jocelyne Guay,Sébastien Guiral,Zheng Huang,Joël Robichaud,Kathryn Skorey,Paul Tawa,Lijing Xu,Lei Zhang,Renata M. Oballa	24
5	Peptidomimetic Inhibitors of Cathepsin K 2010 ·Current Topics in Medicinal Chemistry ·W. Cameron Black	22
6	Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease 2010 ·Bioorganic & Medicinal Chemistry Letters ·Christian Beaulieu,Élise Isabel,(unknown),Frédéric Massé,Christophe Mellon,Nathalie Méthot,Momar Ndao,Deborah A. Nicoll‐Griffith,Doris Lee,(unknown),W. Cameron Black	53
7	Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14 2010 ·Bioorganic & Medicinal Chemistry Letters ·Joël Robichaud,Jean‐François Fournier,Sébastien Gagné,Jacques Yves Gauthier,Martine Hamel,Yongxin Han,Martin Hénault,Stacia Kargman,Jean-François Lévesque,Yaël Mamane,Joseph A. Mancini,Nicolas Morin,(unknown),Jin Wu,W. Cameron Black	44
8	Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Michael J. Boyd,Sheldon N. Crane,Joël Robichaud,John Scheigetz,W. Cameron Black,Nathalie Chauret,Qingping Wang,Frédéric Massé,Renata M. Oballa	23
9	Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities 2007 ·Molecular Pharmacology ·Sylvie Desmarais,W. Cameron Black,Renata M. Oballa,Sonia Lamontagne,Denis Riendeau,Paul Tawa,Le T. Duong,Maureen Pickarski,M. David Percival	61
10	The identification of potent, selective, and bioavailable cathepsin S inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Jacques Yves Gauthier,W. Cameron Black,(unknown),Wanda Cromlish,Sylvie Desmarais,Robert Houle,Sonia Lamontagne,Chun Sing Li,Frédéric Massé,Daniel J. McKay,Marc Ouellet,Joël Robichaud,Jean‐François Truchon,(unknown),Qingping Wang,M. David Percival	51
11	Primary amides as selective inhibitors of cathepsin K 2007 ·Bioorganic & Medicinal Chemistry Letters ·Serge Léger,Christopher I. Bayly,W. Cameron Black,Sylvie Desmarais,Jean‐Pierre Falgueyret,Frédéric Massé,M. David Percival,Jean‐François Truchon	30
12	The Consequences of Lysosomotropism on the Design of Selective Cathepsin K Inhibitors 2006 ·ChemBioChem ·W. Cameron Black,M. David Percival	53
13	Identification of a potent and selective non-basic cathepsin K inhibitor 2006 ·Bioorganic & Medicinal Chemistry Letters ·Chun Sing Li,Denis Deschênes,Sylvie Desmarais,Jean‐Pierre Falgueyret,Jacques Yves Gauthier,Donald B. Kimmel,Serge Léger,Frédéric Massé,Mary E. McGrath,Daniel J. McKay,M. David Percival,Denis Riendeau,Sevgi B. Rodan,Michel Thérien,(unknown),Gregg Wesolowski,Robert Zamboni,W. Cameron Black	67
14	In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia 2005 ·American Journal of Veterinary Research ·Margaret E. McCann,Eric L. Rickes,(unknown),Paul Cunningham,Donghui Zhang,Christine Brideau,W. Cameron Black,Gerard J. Hickey	28
15	An activity-based probe for the determination of cysteine cathepsin protease activities in whole cells 2004 ·Analytical Biochemistry ·Jean‐Pierre Falgueyret,W. Cameron Black,Wanda Cromlish,Sylvie Desmarais,Sonia Lamontagne,Christophe Mellon,Denis Riendeau,Sevgi B. Rodan,Paul Tawa,Gregg Wesolowski,Kathryn E. Bass,Shankar Venkatraman,M. David Percival	45
16	Volunteerism as an Occupation and its Relationship to Health and Wellbeing 2004 ·British Journal of Occupational Therapy ·W. Cameron Black,(unknown)	38
17	3,4-Diaryl-5-hydroxyfuranones: highly selective inhibitors of cyclooxygenase-2 with aqueous solubility 2003 ·Bioorganic & Medicinal Chemistry Letters ·W. Cameron Black,Christine Brideau,Chi-Chung Chan,S. Charleson,Wanda Cromlish,Robert J. Gordon,Erich L. Grimm,Gregory Hughes,Serge Léger,(unknown),Denis Riendeau,Michel Thérien,Zhaoyin Wang,(unknown),Petpiboon Prasit	29
18	A new structural variation on the methanesulfonylphenyl class of selective cyclooxygenase-2 inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),W. Cameron Black,Christine Brideau,(unknown),S. Charleson,Wanda Cromlish,David Claveau,(unknown),Robert J. Gordon,Gillian Greig,Erich L. Grimm,Jocelyne Guay,Cheuk K. Lau,Denis Riendeau,Michel Thérien,Denise M. Visco,Elizabeth Wong,Lijing Xu,Petpiboon Prasit	23
19	Cyclooxygenase-2 Inhibitors. Synthesis and Pharmacological Activities of 5-Methanesulfonamido-1-indanone Derivatives 1995 ·Journal of Medicinal Chemistry ·(unknown),W. Cameron Black,Chi-Chung Chan,Anthony W. Ford‐Hutchinson,J. Y. GAUTHIER,Robert J. Gordon,Daniel Guay,Stacia Kargman,Cheuk K. Lau	62
20	Total synthesis of (+)-A83543A [(+)-lepicidin A] 1993 ·Journal of the American Chemical Society ·David A. Evans,W. Cameron Black	239

About W. Cameron Black

W. Cameron Black is a scholar working on Cancer Research, Immunology and Allergy and Pharmacology, having authored 42 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (14 papers), Protease and Inhibitor Mechanisms (13 papers) and Inflammatory mediators and NSAID effects (9 papers). The work is most often cited by research in Organic Chemistry (821 citations), Pharmaceutical Science (137 citations) and Pharmacology (362 citations). W. Cameron Black has collaborated with scholars based in Canada, United States and France. Frequent co-authors include David A. Evans, M. David Percival, Frédéric Massé, Sylvie Desmarais, Serge Léger, Jean‐Pierre Falgueyret, Denis Riendeau, Christopher I. Bayly, Renata M. Oballa and Sonia Lamontagne. Their work appears in journals such as Journal of the American Chemical Society, Analytical Biochemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact